首页 正文

The Ligustrum lucidum-derived glycoside specnuezhenide alleviates metabolic-associated fatty liver disease in mice via modulation of gut microbiota and the PPARα signalling pathway

{{output}}
Background: Metabolic-associated fatty liver disease (MAFLD), particularly advanced metabolic dysfunction-associated steatohepatitis (MASH), leads to irreversible liver damage. Specnuezhenide (SPE), naturally isolated from Ligust... ...